Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies

This is a Phase 1 (a and b), first in human (FIH), single-arm, open-label, multicenter study to evaluate the safety, tolerability and efficacy of GCC2005 in the treatment of patients with relapsed/refractory (R/R) NK or T-cell malignancies who have received at least two prior lines of therapy.

Participants needed: 53
Trial details
Phase: Phase 1Age: 19-80Biological sex: AllType: InterventionalSponsor: GC Cell CorporationUpdated: Jul 24, 2026Locations: 3
Eligibility criteria

Participants with relapsed or refractory CD5+ NK and T-cell originated malignanc... [+6]

Has T-ALL/T-LBL, CTCL or ALCL. [+10]

Read more
Status: Recruiting

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

PURPOSE: This phase III clinical trial evaluates the efficacy and safety of adjuvant Immuncell-LC therapy combined with gemcitabine versus adjuvant gemcitabine single therapy after R0 or R1 resection in patients with pancreatic ductal adenocarcinoma.

Participants needed: 408
Trial details
Phase: Phase 3Age: 19-80Biological sex: AllType: InterventionalSponsor: GC Cell CorporationUpdated: Nov 22, 2021Locations: 1
Eligibility criteria

Age >/=20 years old, </=80 years old. [+14]

Received anticancer therapy including chemotherapy, biological therapy, immunoth... [+20]

Read more